Incretin mimetics in reducing breast cancer risk [AP6mhrfgcpT]

Incretin mimetics in reducing breast cancer risk [AP6mhrfgcpT]

| 1h 28m 28s | Video has closed captioning.

Neil Iyengar, MD, Memorial Sloan Kettering Cancer Center, New York, NY, comments on the potential of incretin mimetics to reduce breast cancer risk, particularly in postmenopausal women, by inducing weight loss and reducing adipose tissue. Dr Iyengar suggests that lifestyle interventions, such as diet and exercise, may be ideal but notes that incretin mimetics could be a useful starting point, with the goal of maintaining optimal weight or body composition through a lifestyle intervention. This interview took place at the 2024 San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved. #best weight loss pills men #keto gummies australia #energia diet pills